Search Results

Defining ctDNA monitoring and immune modulation in a novel, risk stratified clinical trial for PTLD

Posttransplant lymphoproliferative disorders (PTLD) are a group of lymphomas that arise during immunosuppression following organ transplantation and a…

Leading Treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma Now Available in Tablet Form

WASHINGTON, (June , ) – The U.S. Food and Drug Administration has approved a new tablet formulation of zanubrutinib (Brukinsa®) which is used to treat…

Wawa and The Leukemia & Lymphoma Society Celebrate a Decade of Impact During National Volunteer Week

A Thoughtful Gift from Wawa Brings Relief to Families Facing Blood Cancer Fueling Hope, One Family at a Time WASHINGTON, APRIL , — As Wawa celebrates…

Louis J. DeGennaro, Ph.D., to Retire as President and CEO of The Leukemia & Lymphoma Society

Rye Brook, N.Y., May , – The Leukemia & Lymphoma Society (LLS) announced today the intent of Louis J. DeGennaro, Ph.D., president and CEO, to retire …

Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma

Despite the promise of cell immunotherapy for patients with lymphoma and multiple myeloma, a significant proportion of patients fail to respond or re…

Establishing Hematology Clinical Trial Hubs within the City of Hope Community and Affiliate Network

City of Hope (COH) has embarked on a strategic initiative to optimize our clinical network and increase research capacity at our Community and Affilia…

Improving CAR T-cell Therapy Efficacy in Acute Lymphoblastic Leukemia by Optimizing Design and Placement

Pediatric acute lymphoblastic leukemia (ALL) that is resistant to standard therapy is a challenge that has been partially overcome by therapy, yet re…

Suggested Reading - Final Gifts: Understanding the Special Awareness, Needs, and Communications of The Dying

When someone we love is terminally ill, we are often unprepared to deal with the experience. But the dying have much to tell us and give to us. Final …

Discovery of Aging-Driven Mechanisms Causing Clonal Hematopoiesis (CH) and its Progression to Hematological Malignancy

My research focuses on why and how risk of acute myeloid leukemia (AML) increases with aging. Studying naturally aged mouse models in combination with…

A Discussion on Strategies for New Therapies and Evolving Care in Chronic Lymphocytic Leukemia (CLL)

The Leukemia & Lymphoma Society's New Chief Scientific Officer Excited about What's Next in Blood Cancer Research

Lore Gruenbaum, Ph.D., was promoted to The Leukemia & Lymphoma Society’s (LLS) Chief Scientific Officer (CSO) following the retirement of longtime CSO…

Let's Talk About Childhood Cancer: The Impact of Leukemia in Black Children

Addressing the unseen: Supporting the mental health of people with blood cancer

A look at the mental health impact of blood cancer—and how Blood Cancer United helps patients and caregivers find the support they need.

Blood Cancer United Opens Applications for the Equity In Access Research Program

Blood Cancer United is now accepting Letters of Intent for its Equity in Access Research Program through September , . The Request for Proposals invi…

FDA Approval of AML Therapy is a Significant Advance for Blood Cancer Patients

Rye Brook, N.Y. (September , ) – The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), one of the most deadly…

LLS Commits $1 Million to Blood Cancer Patients Impacted by Hurricane Harvey

Rye Brook, NY – September , – In the wake of the destruction caused by Hurricane Harvey, The Leukemia & Lymphoma Society (LLS) announced today that i…

New Senate Bill Would Put Cancer Care Out of Reach for Many

Rye Brook, N.Y. (September , ) - U.S. Senators Lindsay Graham (South Carolina) and Bill Cassidy (Louisiana) recently introduced a bill to dismantle po…

"Nashville" Star Charles Esten Brings Light to the Dark World of Cancer

Contact: Marcie [email protected]() -

Foundation Beyond Belief Raises $900,000 for Cancer Cures Through Light The Night

For Immediate ReleaseContact: Andrea Greif() [email protected] Plains, NY (May , ) - Foundation Beyond Belief (FBB), a team of atheists…

Bringing Light To The Darkness Of Cancer: LLS's Partners Are Saving Lives

Rye Brook, NY, (September ,) - As The Leukemia & Lymphoma Society’s (LLS) Light The Night fundraising campaign continues to beat growth records, leadi…

New Report: Blood Cancer United Proposes Industry Reforms to Lower Healthcare Costs

Soaring healthcare costs and industry practices contributing to them are increasingly making cancer treatment out of reach for many U.S. patients, cau…

National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial

“Coloring Outside the Lines” follows the journeys of four patients with aggressive leukemia and the groundbreaking clinical trial designed to save th…

Medicaid is a lifesaver for blood cancer patients: We need to protect it

Breakthrough treatments are transforming what it means to receive a blood cancer diagnosis for hundreds of thousands of people across the country, giv…

Blood Cancer United Welcomes Three New Members to its Board of Directors

New Members Bring Extensive Expertise in Science, Drug Development & Legal Counsel to the Global Leader in Creating a World Without Blood Cancer …

Hundreds to Climb Iconic Bank of America Tower to End Blood Cancer

The Leukemia & Lymphoma Society aims to turn vision of a world without blood cancer into a reality through epic “Big Climb”